Skip to main content
. 2022 Jan 24;22:100. doi: 10.1186/s12885-022-09197-w

Fig. 1.

Fig. 1

Average proliferation over time for ovarian cancer cells treated with azacitidine, carboplatin and combination azacitidine and carboplatin. Data displayed is mean ± SEM of triplicates of three independent experiments for 8 cell lines